Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Bexobrutideg (NX-5948), a novel Bruton's tyrosine kinase (BTK) degrader, shows high clinical activity and tolerable safety in patients with Waldenström macroglobulinemia: Updated results from an ongoing Phase 1a/b study

Nirav Shah, Scott Huntington, David Lewis, Talha Munir, Graham Collins, Alvaro Alencar, Kim Linton, Zulfa Omer, Dima El-Sharkawi, Mary Gleeson, Pamela McKay, Jeanette Doorduijn, Jeffery Smith, Daniel Morillo, Pau Abrisqueta, Sarah Injac, Astrid Pulles

Blood (2025) 146 (Supplement 1): 5359.

https://doi.org/10.1182/blood-2025-5359

Published: 2025

Journal Articles

Spatially resolved profiling reveals the perifollicular border zone as a key immunologic hub in follicular lymphoma undergoing mosunetuzumab therapy

Ari Pelcovits, Makayla Pardo, Diana Treaba, Anna Chorzalska, Patrycja Dubielecka, Thomas Ollila, John Reagan, Matthew Matasar, Scott Huntington, Petra den Hollander, Sendurai Mani, Adam Olszewski

Blood (2025) 146 (Supplement 1): 5327.

https://doi.org/10.1182/blood-2025-5327

Published: 2025

Journal Articles

Concurrent TP53 loss-of-function and epigenetic modifier mutations as a potential predictor of chemoimmunotherapy failure in DLBCL & hgbl

Arjun Ravishankar, Iris Isufi, Scott Huntington, Stuart Seropian, Francine Foss, Tarsheen Sethi, Shalin Kothari

Blood (2025) 146 (Supplement 1): 7071.

https://doi.org/10.1182/blood-2025-7071

Published: 2025

Journal Articles

Inequity in travel burden among patients receiving bispecific antibodies (BsAbs) for diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL): A real-world study of Medicare beneficiaries in the United States (US)

Zachary Frosch, Anthony Masaquel, Esprit Ma, Eric Zuk, Matthew Davis, Fadoua El Moustaid, Mei Wu, Carolina Reyes, Lourenia Cassoli, Scott Huntington

Blood (2025) 146 (Supplement 1): 2622.

https://doi.org/10.1182/blood-2025-2622

Published: 2025

Journal Articles

Prognostic impact of cytogenetic abnormalities in aggressive T-cell lymphomas: Defining high-risk subgroups through conventional karyotyping.

Ahmad Kiwan, Autumn Diadamo, Jia Di Wen, Tariq Kewan, Alexa Siddon, Shalin Kothari, Iris Isufi, Stuart Seropian, Scott Huntington, Francesca Montanari, Mina Xu, Peining Li, Michael Girardi, Tarsheen Sethi, Francine Foss

Blood (2025) 146 (Supplement 1): 1759.

https://doi.org/10.1182/blood-2025-1759

Published: 2025

Journal Articles

Causes of death in chronic lymphocytic leukemia/small lymphocytic lymphoma during the novel agent era: A population-based analysis

Mengyang Di, Scott Huntington, Jenna Voutsinas, Qian Wu, Scott Ramsey, Jennifer Huang, Ajay Gopal, Mazyar Shadman

Blood (2025) 146 (Supplement 1): 4520.

https://doi.org/10.1182/blood-2025-4520

Published: 2025

Journal Articles

Real-world rates of tyrosine kinase inhibitor prescription approval, fill, and adherence and associated factors in a national sample of patients with chronic myeloid leukemia

Pengxiang Li, Anoosha Shukla, John Lin, Zhi Geng, Scott Huntington, Jalpa Doshi

Blood (2025) 146 (Supplement 1): 2651.

https://doi.org/10.1182/blood-2025-2651

Published: 2025

Journal Articles

Early discharge program cost savings for patients with newly diagnosed acute myeloid leukemia after intensive induction chemotherapy

Cameron Hunter, Karthik Chetlapalli, Satoko Ito, Jan Philipp Bewersdorf, Prajwal Boddu, Sabrina Browning, Stephanie Halene, Terri Parker, Scott Huntington, Shalin Kothari, Lourdes Mendez, Natalia Neparidze, Tarsheen Sethi, Maximilian Stahl, Nikolai Podoltsev, Amer Zeidan, Rory Shallis, George Goshua

Blood (2025) 146 (Supplement 1): 6208.

https://doi.org/10.1182/blood-2025-6208

Published: 2025

Journal Articles

Treatment inequities in newly diagnosed diffuse large B-cell lymphoma (DLBCL): Comparing polatuzumab vedotin in combination with rituximab, cyclophosphamide, doxorubicin and prednisone (Pola-R-CHP) vs rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) among Medicare beneficiaries

John Vaughn, Anthony Masaquel, Carolina Reyes, Farah Hossain, Eric Zuk, Rebecca Straubing, Matthew Davis, Scott Huntington

Blood (2025) 146 (Supplement 1): 4489.

https://doi.org/10.1182/blood-2025-4489

Published: 2025

Journal Articles

Real-world effectiveness of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin and prednisone (R-CHP) compared with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) among elderly Medicare beneficiaries with diffuse large B-cell lymphoma (DLBCL) in the United States

Matthew Matasar, Anthony Masaquel, Carolina Reyes, Farah Hossain, Eric Zuk, Rebecca Straubing, Matthew Davis, Scott Huntington

Blood (2025) 146 (Supplement 1): 4486.

https://doi.org/10.1182/blood-2025-4486

Published: 2025

Journal Articles

Real-world overall survival and time to next treatment among elderly United States Medicare beneficiaries with chronic lymphocytic leukemia in the front-line setting

Scott Huntington, Justin Puckett, Beenish Manzoor, Nnadozie Emechebe, Sophia Li, Sachin Kamal-Bahl, Carolina Reyes, Holly Budlong, Jalpa Doshi

Blood (2025) 146 (Supplement 1): 6259.

https://doi.org/10.1182/blood-2025-6259

Published: 2025

Journal Articles

Mosunetuzumab with response-driven lenalidomide augmentation achieves high response rates and immune reprogramming in untreated follicular and marginal zone lymphoma: A multicenter Phase 2 trial

Adam Olszewski, Matthew Matasar, Scott Huntington, Dennis Bonal, Thomas Ollila, Ari Pelcovits, Yun Kyoung Tiger, John Reagan, Anna Chorzalska, John Morgan, Makayla Pardo, Jessica McMahon, Stephen Donnelly, Caylee Carmody, Jeannine Margolis, Charles Milrod, Patrycja Dubielecka

Blood (2025) 146 (Supplement 1): 1003.

https://doi.org/10.1182/blood-2025-1003

Published: 2025

Journal Articles

Patient assistance for drug cost sharing: Highlighting the variability across pharmaceutical manufacturers of specialty oral anticancer medications for blood cancers

Anoosha Shukla, John Lin, Pengxiang Li, Scott Huntington, Jalpa Doshi

Blood (2025) 146 (Supplement 1): 7932.

https://doi.org/10.1182/blood-2025-7932

Published: 2025

Journal Articles

Aberrant circulating CD4+ CD26- T-cells in T-cell rich B-cell lymphomas: Diagnostic pitfall or biomarker?

Arjun Ravishankar, Pohan Chen, Mina Xu, Demetrios Braddock, Alexa Siddon, Iris Isufi, Scott Huntington, Stuart Seropian, Francine Foss, Shalin Kothari, Tarsheen Sethi

Blood (2025) 146 (Supplement 1): 7182.

https://doi.org/10.1182/blood-2025-7182

Published: 2025

Journal Articles

Financial Incentives and Rituximab Maintenance: Association of Treatment Location with Prolonged Maintenance in Non-Hodgkin Lymphoma Patients Treated in the United States

Scott Huntington, MDMPH, Jessica Hoag, PhD, Weiwei Zhu, Ms, Cary P Gross, MD, Amy J. Davidoff, PhD MS

Blood (2017) 130 (Supplement 1): 2120.

https://doi.org/10.1182/blood.V130.Suppl_1.2120.2120

Published: 2017

Journal Articles

The Impact of Phlebotomy and Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients with Polycythemia Vera

Nikolai A. Podoltsev, MD PhD, Mengxin Zhu, MPH, Amer M. Zeidan, MD, Rong Wang, PhD, Amy J. Davidoff, PhD MS, Scott Huntington, MDMPH, Smith Giri, MBBS, Steven D. Gore, MD, Xiaomei Ma, MD PhD

Blood (2017) 130 (Supplement 1): 354.

https://doi.org/10.1182/blood.V130.Suppl_1.354.354

Published: 2017

Journal Articles

The Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients with Essential Thrombocythemia

Nikolai A. Podoltsev, MD PhD, Mengxin Zhu, MPH, Amer M. Zeidan, MD, Rong Wang, PhD, Amy J. Davidoff, PhD MS, Smith Giri, MBBS, Scott Huntington, MDMPH, Steven D. Gore, MD, Xiaomei Ma, MD PhD

Blood (2017) 130 (Supplement 1): 351.

https://doi.org/10.1182/blood.V130.Suppl_1.351.351

Published: 2017

Journal Articles

Long-Term Survival of Older Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agent Therapy: A Large Population-Based Analysis

Maximilian Stahl, MD, Xin Hu, MS, Rong Wang, PhD, Xiaomei Ma, MD PhD, Scott Huntington, MDMPH, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Gregory A. Abel, MD, Amy J. Davidoff, PhD MS, Amer M. Zeidan, MD

Blood (2017) 130 (Supplement 1): 343.

https://doi.org/10.1182/blood.V130.Suppl_1.343.343

Published: 2017

Journal Articles

Relationship between Hospital Volume and Inpatient Mortality Among Patients Diagnosed with Thrombotic Thrombocytopenic Purpura (TTP) in the United States

Smith Giri, MBBS, Ranjan Pathak, MD, Robert Franklin, MD, Nikolai A. Podoltsev, MD PhD, Scott Huntington, MDMPH, Kathan Dilipbhai Mehta, MBBS, MPH, Amer M. Zeidan, MD

Blood (2017) 130 (Supplement 1): 675.

https://doi.org/10.1182/blood.V130.Suppl_1.675.675

Published: 2017

Journal Articles

The Changing Face of Adult Posttransplant Lymphoproliferative Disorder: Dramatic Changes in Histology between 1999-2013

Donald Edward Tsai, MD PhD, Scott Huntington, MDMPH, Ran Reshef, MDMSc, Abraham Shaked, MD, Roy Bloom, MD, Vivek Ahya, Lee Goldberg, MD, Albert Chung, Fotini Debonera, Stephen J. Schuster, MD, Stephen Joseph Bagley, MD

Blood (2017) 130 (Supplement 1): 1574.

https://doi.org/10.1182/blood.V130.Suppl_1.1574.1574

Published: 2017

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Bexobrutideg (NX-5948), a novel Bruton's tyrosine kinase (BTK) degrader, shows high clinical activity and tolerable safety in patients with Waldenström macroglobulinemia: Updated results from an ongoing Phase 1a/b study

Spatially resolved profiling reveals the perifollicular border zone as a key immunologic hub in follicular lymphoma undergoing mosunetuzumab therapy

Concurrent TP53 loss-of-function and epigenetic modifier mutations as a potential predictor of chemoimmunotherapy failure in DLBCL & hgbl

Inequity in travel burden among patients receiving bispecific antibodies (BsAbs) for diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL): A real-world study of Medicare beneficiaries in the United States (US)

Prognostic impact of cytogenetic abnormalities in aggressive T-cell lymphomas: Defining high-risk subgroups through conventional karyotyping.

Causes of death in chronic lymphocytic leukemia/small lymphocytic lymphoma during the novel agent era: A population-based analysis

Real-world rates of tyrosine kinase inhibitor prescription approval, fill, and adherence and associated factors in a national sample of patients with chronic myeloid leukemia

Early discharge program cost savings for patients with newly diagnosed acute myeloid leukemia after intensive induction chemotherapy

Real-world overall survival and time to next treatment among elderly United States Medicare beneficiaries with chronic lymphocytic leukemia in the front-line setting

Mosunetuzumab with response-driven lenalidomide augmentation achieves high response rates and immune reprogramming in untreated follicular and marginal zone lymphoma: A multicenter Phase 2 trial

Patient assistance for drug cost sharing: Highlighting the variability across pharmaceutical manufacturers of specialty oral anticancer medications for blood cancers

Aberrant circulating CD4+ CD26- T-cells in T-cell rich B-cell lymphomas: Diagnostic pitfall or biomarker?

Financial Incentives and Rituximab Maintenance: Association of Treatment Location with Prolonged Maintenance in Non-Hodgkin Lymphoma Patients Treated in the United States

The Impact of Phlebotomy and Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients with Polycythemia Vera

The Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients with Essential Thrombocythemia

Long-Term Survival of Older Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agent Therapy: A Large Population-Based Analysis

Relationship between Hospital Volume and Inpatient Mortality Among Patients Diagnosed with Thrombotic Thrombocytopenic Purpura (TTP) in the United States

The Changing Face of Adult Posttransplant Lymphoproliferative Disorder: Dramatic Changes in Histology between 1999-2013

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only